CanSino's #COVID_19 #vaccine candidate approved for military use in China
2082 Monday, 29 June, 2020, 17:25 China's military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and somewhat efficient, the company said on Monday. The Ad5-nCoV is one of the eight vaccine candidates being developed by Chinese companies and researchers approved to be moved into human trials for the respiratory disease caused by the new coronavirus. The shot also won approval for human testing in Canada. China’s Central Military Commission approved the use of the vaccine by the military on June 25 for a period of one year, CanSino said in a filing. The vaccine candidate was developed jointly by CanSino and the Beijing Institute of Biotechnology in the Academy of Military Medical Sciences. “The Ad5-nCoV is currently limited to military use only and its use cannot be expanded to a broader vaccination range without the approval of the Logistics Support Department,” CanSino said, referring to the Central Military Commission department where the military use of the vaccine was approved. |
SpaceX Starship ‘Lost’ After Reaching Space During Third Test Flight
599414.03.2024, 20:27Neuralink's first human patient can control mouse through thinking, says Elon Musk
883520.02.2024, 15:24A Bronze Age lip-paint from southeastern Iran (photo)
1007806.02.2024, 20:24Apple thinks iOS 18 might be the ‘biggest’ iOS update ever
1024403.02.2024, 20:06Elon Musk's Neuralink implants brain chip in first human (video)
1015430.01.2024, 10:30Nokia smartphone brand will soon disappear: Why has it failed to gain a place in the market?
1179918.01.2024, 23:48For the first time in 30 years, your keyboard is about to be changed (video)
1322905.01.2024, 17:24Coronal mass ejection from colossal New Year's Eve solar flare will strike Earth today
1382005.01.2024, 00:18